Encouraging results from Phase 1/2 study of mirdametinib in pediatric patients with low-grade glioma also to be presented in oral session at SNO – STAMFORD, Conn., (GLOBE NEWSWIRE) -- SpringWorks ...

and a further 36 in hematological malignancies. For more than 25 years, Global Healing has been helping health-conscious ...

While there is no REMS program required for obe-cel, there is a boxed warning for CRS, neurologic toxicities, and secondary ...

Samer A. Al'Hadidi, MD, MS, discusses the response and survival of 2 quadruplet therapy trials for patients with ...

The COVID-19 pandemic has prompted the rapid development and administration of various vaccines worldwide, with some reports linking these vaccines to immune thrombotic thrombocytopenic purpura (TTP).

Stephens analyst has initiated coverage on ADC Therapeutics SA (NYSE:ADCT), a commercial-stage oncology-focused biotechnology ...

The partners are advancing a pipeline of engineered DNase I therapies designed to work with CAR T cells to kill tumor cells.

A PA Student used his experience in the military, and his own health journal, to help other veterans apply and receive ...

A World Bank report reveals that nearly 45% of Indonesians are exposed to lead from household paint, endangering millions, ...

A disease historically associated with malnourishment on sailing vessels may have a new, modern culprit: Bariatric surgery.

The second case involves a 45-year-old female who experienced fever and muscle soreness five days after her second dose of ...